OPTUS Pharmaceutical Co., Ltd. (131030.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩5,850 (+1.74%) as of
Key statistics
- Market cap
- 101.63B
- Dividend yield
- 0.00%
- 52-week range
- 4,610.00 – 20,750.00
- Beta
- -0.08
- Revenue (TTM)
- 94.47B
- Profit margin
- 14.55%
- Volume
- 14.02k
About OPTUS Pharmaceutical Co., Ltd.
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Cheongju, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.